BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,197,837 | +5.1% | 451,672 | +4.5% | 0.00% | 0.0% |
| Q2 2023 | $3,043,694 | -44.7% | 432,343 | -34.4% | 0.00% | -50.0% |
| Q1 2023 | $5,499,955 | +40.4% | 659,467 | +93.3% | 0.00% | +33.3% |
| Q4 2022 | $3,917,183 | -34.5% | 341,218 | -28.1% | 0.00% | -25.0% |
| Q3 2022 | $5,980,000 | +39.3% | 474,579 | +16.9% | 0.00% | +33.3% |
| Q2 2022 | $4,294,000 | +293.6% | 405,888 | +505.2% | 0.00% | +200.0% |
| Q1 2022 | $1,091,000 | -79.7% | 67,064 | -82.8% | 0.00% | -66.7% |
| Q4 2021 | $5,386,000 | +131.1% | 388,878 | +139.8% | 0.00% | +200.0% |
| Q3 2021 | $2,331,000 | -51.2% | 162,189 | -46.3% | 0.00% | -66.7% |
| Q2 2021 | $4,772,000 | +29.6% | 301,814 | -16.7% | 0.00% | +50.0% |
| Q1 2021 | $3,683,000 | +333.8% | 362,165 | +218.1% | 0.00% | – |
| Q4 2020 | $849,000 | +227.8% | 113,861 | +51.6% | 0.00% | – |
| Q3 2020 | $259,000 | -83.7% | 75,092 | -77.4% | 0.00% | -100.0% |
| Q2 2020 | $1,585,000 | +403.2% | 332,802 | +110.9% | 0.00% | – |
| Q1 2020 | $315,000 | -55.7% | 157,769 | -23.5% | 0.00% | – |
| Q4 2019 | $711,000 | -32.5% | 206,115 | -44.0% | 0.00% | -100.0% |
| Q3 2019 | $1,054,000 | -29.3% | 367,953 | -6.5% | 0.00% | 0.0% |
| Q2 2019 | $1,491,000 | +442.2% | 393,448 | +1063.3% | 0.00% | – |
| Q1 2019 | $275,000 | -86.9% | 33,821 | -87.0% | 0.00% | -100.0% |
| Q4 2018 | $2,099,000 | +85.8% | 259,916 | +75.5% | 0.00% | +100.0% |
| Q3 2018 | $1,130,000 | +100.4% | 148,098 | +50.6% | 0.00% | – |
| Q2 2018 | $564,000 | -18.3% | 98,333 | -32.0% | 0.00% | -100.0% |
| Q1 2018 | $690,000 | -15.6% | 144,602 | -13.1% | 0.00% | 0.0% |
| Q4 2017 | $818,000 | +270.1% | 166,481 | +294.0% | 0.00% | – |
| Q3 2017 | $221,000 | -57.2% | 42,255 | -54.4% | 0.00% | – |
| Q2 2017 | $516,000 | +288.0% | 92,681 | +485.1% | 0.00% | – |
| Q1 2017 | $133,000 | -60.3% | 15,840 | -70.1% | 0.00% | – |
| Q4 2016 | $335,000 | +2476.9% | 52,891 | +1829.6% | 0.00% | – |
| Q3 2016 | $13,000 | -78.7% | 2,741 | -87.2% | 0.00% | – |
| Q2 2016 | $61,000 | -61.1% | 21,438 | -61.3% | 0.00% | – |
| Q1 2016 | $157,000 | -38.9% | 55,464 | +123.3% | 0.00% | – |
| Q4 2015 | $257,000 | -63.4% | 24,835 | -59.8% | 0.00% | -100.0% |
| Q3 2015 | $703,000 | +66.2% | 61,707 | +117.5% | 0.00% | – |
| Q2 2015 | $423,000 | +47.9% | 28,368 | -10.4% | 0.00% | – |
| Q1 2015 | $286,000 | -26.5% | 31,674 | -0.7% | 0.00% | – |
| Q4 2014 | $389,000 | +472.1% | 31,909 | +355.9% | 0.00% | – |
| Q3 2014 | $68,000 | -50.7% | 6,999 | -35.0% | 0.00% | – |
| Q2 2014 | $138,000 | +51.6% | 10,774 | +25.2% | 0.00% | – |
| Q1 2014 | $91,000 | +82.0% | 8,603 | +31.0% | 0.00% | – |
| Q4 2013 | $50,000 | +233.3% | 6,568 | +221.8% | 0.00% | – |
| Q3 2013 | $15,000 | +400.0% | 2,041 | -6.8% | 0.00% | – |
| Q2 2013 | $3,000 | – | 2,190 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |